For technical usage questions about the BinaxNOW™ test, contact Abbott directly at: Technical support: ts.scr@abbott.com or 1-800-257-9525
For all other questions related to your distribution, please contact HHSBINAX@hhs.gov, this inbox was established to coordinate the distribution of government procured Abbott BinaxNOW™kits. This inbox should NOT be used to request kits for facilities not currently receiving these tests.
Useful Links:
For training videos & documentation and other important links, please refer the following information:
For policy regarding performance of antigen tests authorized by the FDA under an Emergency Use Authorization (EUA) at the point of care or in patient care settings operating under a CLIA Certificate of Waiver, please refer to CMS’s policy here and PREP Act guidance here.
For FDA recommendations to health care providers who are ordering authorized tests outside their authorization (e.g., antigen tests for asymptomatic individuals), please see FDA’s FAQ on Testing for SARS-CoV-2.
Live Next Tuesday: Revised Regulation on COVID-19 Employee Leave - Join Rachael Jeanfreau and E. Fredrick Preis, Jr., partners at Breazeale, Sachse & Wilson, L.L.P., on September 29 at 2 p.m. ET for an overview of the revised regulation clarifying workers’ rights and employers’ responsibilities under the Families First Coronavirus Response Act paid leave provisions. Register for this free, members-only event today! Note: This is a live presentation and will not be recorded; no CEs are available.
Register for the Annual Meeting Virtual Experience.This year’s program has been designed to address the current realities facing our field—and the action required to respond to the unprecedented future ahead of us. Our featured speakers, keynote presentations, and sessions will focus on resilience, resolve, and reimagining the future of our field. View the program and register today.
